<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p76" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_76{left:36px;bottom:25px;letter-spacing:0.07px;word-spacing:0.01px;}
#t2_76{left:341px;bottom:30px;}
#t3_76{left:348px;bottom:25px;letter-spacing:0.11px;}
#t4_76{left:377px;bottom:30px;}
#t5_76{left:381px;bottom:25px;letter-spacing:0.07px;word-spacing:-0.1px;}
#t6_76{left:540px;bottom:30px;}
#t7_76{left:546px;bottom:25px;letter-spacing:0.07px;}
#t8_76{left:44px;bottom:77px;letter-spacing:0.1px;word-spacing:-0.05px;}
#t9_76{left:44px;bottom:63px;letter-spacing:0.1px;}
#ta_76{left:285px;bottom:860px;letter-spacing:-0.32px;word-spacing:0.06px;}
#tb_76{left:285px;bottom:827px;letter-spacing:-0.25px;}
#tc_76{left:996px;bottom:873px;letter-spacing:-0.1px;}
#td_76{left:1043px;bottom:853px;letter-spacing:-0.22px;word-spacing:0.13px;}
#te_76{left:1093px;bottom:833px;letter-spacing:-0.09px;}
#tf_76{left:1120px;bottom:28px;letter-spacing:0.24px;}
#tg_76{left:36px;bottom:165px;}
#th_76{left:43px;bottom:159px;letter-spacing:0.12px;}
#ti_76{left:706px;bottom:159px;letter-spacing:0.13px;word-spacing:-0.05px;}
#tj_76{left:1007px;bottom:159px;letter-spacing:0.12px;}
#tk_76{left:1037px;bottom:159px;letter-spacing:0.13px;}
#tl_76{left:1111px;bottom:159px;letter-spacing:0.08px;}
#tm_76{left:36px;bottom:148px;}
#tn_76{left:46px;bottom:142px;letter-spacing:0.11px;word-spacing:0.02px;}
#to_76{left:255px;bottom:142px;letter-spacing:0.14px;}
#tp_76{left:326px;bottom:142px;letter-spacing:0.13px;}
#tq_76{left:607px;bottom:142px;letter-spacing:0.04px;}
#tr_76{left:689px;bottom:142px;letter-spacing:0.12px;}
#ts_76{left:718px;bottom:142px;letter-spacing:0.06px;}
#tt_76{left:796px;bottom:142px;letter-spacing:0.11px;word-spacing:0.02px;}
#tu_76{left:45px;bottom:125px;letter-spacing:0.12px;}
#tv_76{left:36px;bottom:114px;}
#tw_76{left:46px;bottom:108px;letter-spacing:0.12px;word-spacing:-0.03px;}
#tx_76{left:557px;bottom:108px;}
#ty_76{left:36px;bottom:525px;letter-spacing:-0.09px;}
#tz_76{left:36px;bottom:506px;letter-spacing:-0.09px;}
#t10_76{left:275px;bottom:686px;letter-spacing:-0.09px;}
#t11_76{left:275px;bottom:668px;letter-spacing:-0.1px;}
#t12_76{left:622px;bottom:706px;letter-spacing:-0.09px;}
#t13_76{left:622px;bottom:688px;letter-spacing:-0.1px;}
#t14_76{left:889px;bottom:695px;letter-spacing:-0.1px;}
#t15_76{left:622px;bottom:670px;letter-spacing:-0.1px;}
#t16_76{left:622px;bottom:651px;letter-spacing:-0.11px;}
#t17_76{left:622px;bottom:778px;letter-spacing:0.3px;}
#t18_76{left:275px;bottom:524px;letter-spacing:-0.09px;}
#t19_76{left:275px;bottom:506px;letter-spacing:-0.1px;}
#t1a_76{left:275px;bottom:363px;letter-spacing:-0.09px;}
#t1b_76{left:275px;bottom:345px;letter-spacing:-0.1px;}
#t1c_76{left:622px;bottom:550px;letter-spacing:-0.09px;}
#t1d_76{left:622px;bottom:531px;letter-spacing:-0.1px;}
#t1e_76{left:889px;bottom:539px;letter-spacing:-0.1px;}
#t1f_76{left:622px;bottom:513px;letter-spacing:-0.1px;}
#t1g_76{left:622px;bottom:495px;letter-spacing:-0.1px;}
#t1h_76{left:864px;bottom:502px;letter-spacing:-0.1px;}
#t1i_76{left:885px;bottom:495px;letter-spacing:-0.1px;}
#t1j_76{left:622px;bottom:383px;letter-spacing:-0.1px;}
#t1k_76{left:788px;bottom:391px;letter-spacing:-0.1px;}
#t1l_76{left:809px;bottom:383px;letter-spacing:-0.09px;}
#t1m_76{left:622px;bottom:365px;letter-spacing:-0.1px;}
#t1n_76{left:622px;bottom:347px;letter-spacing:-0.09px;}
#t1o_76{left:622px;bottom:328px;letter-spacing:-0.1px;}
#t1p_76{left:889px;bottom:336px;letter-spacing:-0.1px;}
#t1q_76{left:1065px;bottom:537px;letter-spacing:-0.1px;}
#t1r_76{left:1065px;bottom:519px;letter-spacing:-0.09px;}
#t1s_76{left:1065px;bottom:501px;letter-spacing:-0.08px;}
#t1t_76{left:1072px;bottom:447px;letter-spacing:-0.09px;}
#t1u_76{left:1072px;bottom:428px;letter-spacing:-0.06px;}
#t1v_76{left:1072px;bottom:410px;letter-spacing:-0.08px;}
#t1w_76{left:1072px;bottom:392px;letter-spacing:-0.09px;}
#t1x_76{left:1072px;bottom:373px;letter-spacing:-0.25px;}
#t1y_76{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_76{font-size:9px;font-family:ArialMT_5tg;color:#000;}
.s1_76{font-size:5px;font-family:ArialMT_5tg;color:#000;}
.s2_76{font-size:12px;font-family:Arial-BoldMT_5te;color:#000;}
.s3_76{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s4_76{font-size:17px;font-family:ArialMT_5tg;color:#0065A4;}
.s5_76{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s6_76{font-size:12px;font-family:ArialMT_5tg;color:#000;}
.s7_76{font-size:15px;font-family:ArialMT_5tg;color:#000;}
.s8_76{font-size:15px;font-family:ArialMT_5tg;color:#0065A4;}
.s9_76{font-size:14px;font-family:Arial-BoldMT_5te;color:#000;}
.sa_76{font-size:14px;font-family:Arial-BoldMT_jz;color:#000;}
.sb_76{font-size:17px;font-family:Arial-BoldMT_5te;color:#0065A4;}
.sc_76{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts76" type="text/css" >

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: Arial-BoldMT_jz;
	src: url("fonts/Arial-BoldMT_jz.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

</style>
<div id="pg76Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg76" style="-webkit-user-select: none;"><object width="1210" height="935" data="76/76.svg" type="image/svg+xml" id="pdf76" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_76" class="t s0_76">Version 4.2024, 5/1/2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t2_76" class="t s1_76">® </span>
<span id="t3_76" class="t s0_76">(NCCN </span>
<span id="t4_76" class="t s1_76">® </span>
<span id="t5_76" class="t s0_76">), All rights reserved. NCCN Guidelines </span>
<span id="t6_76" class="t s1_76">® </span>
<span id="t7_76" class="t s0_76">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="t8_76" class="t s2_76">Note: All recommendations are category 2A unless otherwise indicated. </span>
<span id="t9_76" class="t s2_76">Clinical Trials: NCCN believes that the best management of any patient with cancer is in a clinical trial. Participation in clinical trials is especially encouraged. </span>
<span id="ta_76" class="t s3_76">NCCN Guidelines Version 4.2024 </span>
<span id="tb_76" class="t s3_76">Occult Primary </span>
<span id="tc_76" class="t s4_76">NCCN Guidelines Index </span>
<span id="td_76" class="t s4_76">Table of Contents </span>
<span id="te_76" class="t s4_76">Discussion </span>
<span id="tf_76" class="t s5_76">OCC-4 </span>
<span id="tg_76" class="t s6_76">f </span>
<span id="th_76" class="t s7_76">Whether HPV or EBV positive status may help to define the radiation fields is being investigated [s</span><span id="ti_76" class="t s8_76">ee Principles of Radiation Therapy (OCC-A) </span><span id="tj_76" class="t s7_76">and </span><span id="tk_76" class="t s8_76">Discussion</span><span id="tl_76" class="t s7_76">]. </span>
<span id="tm_76" class="t s6_76">p </span>
<span id="tn_76" class="t s7_76">Treatment for nasopharyngeal </span><span id="to_76" class="t s8_76">(NASO-2) </span><span id="tp_76" class="t s7_76">and p16-positive oropharyngeal cancers (</span><span id="tq_76" class="t s8_76">ORPHPV-3 </span><span id="tr_76" class="t s7_76">and </span><span id="ts_76" class="t s8_76">ORPHPV-4</span><span id="tt_76" class="t s7_76">) to guide management of EBV-positive and p16- </span>
<span id="tu_76" class="t s7_76">positive occult primary tumors. </span>
<span id="tv_76" class="t s6_76">q </span>
<span id="tw_76" class="t s8_76">Principles of Systemic Therapy for Non-Nasopharyngeal Cancers (SYST-A)</span><span id="tx_76" class="t s7_76">. </span>
<span id="ty_76" class="t s5_76">Post neck </span>
<span id="tz_76" class="t s5_76">dissection </span>
<span id="t10_76" class="t s5_76">N1 without extranodal </span>
<span id="t11_76" class="t s5_76">extension </span>
<span id="t12_76" class="t s5_76">RT (target volume determined by tumor size, nodal </span>
<span id="t13_76" class="t s5_76">station, and HPV and EBV status) </span>
<span id="t14_76" class="t s9_76">f,p </span>
<span id="t15_76" class="t s5_76">or </span>
<span id="t16_76" class="t s5_76">Observe </span>
<span id="t17_76" class="t s5_76">TREATMENT </span>
<span id="t18_76" class="t s5_76">N2,N3 without </span>
<span id="t19_76" class="t s5_76">extranodal extension </span>
<span id="t1a_76" class="t s5_76">Extranodal </span>
<span id="t1b_76" class="t s5_76">extension </span>
<span id="t1c_76" class="t s5_76">RT (target volume determined by tumor size, nodal </span>
<span id="t1d_76" class="t s5_76">station, and HPV and EBV status) </span>
<span id="t1e_76" class="t s9_76">f,p </span>
<span id="t1f_76" class="t s5_76">or </span>
<span id="t1g_76" class="t s5_76">Consider systemic therapy/RT </span>
<span id="t1h_76" class="t sa_76">f,q </span>
<span id="t1i_76" class="t s5_76">(category 2B) </span>
<span id="t1j_76" class="t s5_76">Systemic therapy/RT </span>
<span id="t1k_76" class="t sa_76">f,q </span>
<span id="t1l_76" class="t s5_76">(category 1) </span>
<span id="t1m_76" class="t s5_76">or </span>
<span id="t1n_76" class="t s5_76">RT (target volume determined by tumor size, nodal </span>
<span id="t1o_76" class="t s5_76">station, and HPV and EBV status) </span>
<span id="t1p_76" class="t s9_76">f,p </span>
<span id="t1q_76" class="t s5_76">Follow-up </span>
<span id="t1r_76" class="t sb_76">(FOLL-A, 1 </span>
<span id="t1s_76" class="t sb_76">of 2) </span>
<span id="t1t_76" class="t s5_76">Recurrent </span>
<span id="t1u_76" class="t s5_76">or </span>
<span id="t1v_76" class="t s5_76">persistent </span>
<span id="t1w_76" class="t s5_76">disease </span>
<span id="t1x_76" class="t sb_76">(ADV-3) </span>
<span id="t1y_76" class="t sc_76">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
